XML 65 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefits (Tables)
12 Months Ended
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
Share-based payments recorded in salaries and benefits expense are as follows:
 
Year Ended December 31,
2017
 
2016
 
2015
 
(In thousands)
Stock option and ESPP expense
$
480

 
$
437

 
$
518

Nonvested share expense
7,794

 
6,293

 
5,723

Subtotal
8,274

 
6,730

 
6,241

Tax benefit
3,188

 
2,574

 
2,367

Stock-based compensation expense, net of tax benefit
$
5,086

 
$
4,156

 
$
3,874

Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of option activity under the 2009 Plan for the year ended December 31, 2017 is as follows:
 
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term in Years
 
Aggregate
Intrinsic Value
(in 000’s)
Outstanding at December 31, 2016
656,400

 
$
13.11

 
 
 
 
Granted

 
$

 
 
 
 
Exercised
109,400

 
$
8.21

 
 
 
 
Forfeited
12,798

 
$
28.85

 
 
 
 
Expired
115,547

 
$
29.73

 
 
 
 
Outstanding at December 31, 2017
418,655

 
$
9.32

 
1.81 years
 
$
2,795.0

Exercisable at December 31, 2017
418,655

 
$
9.32

 
1.81 years
 
$
2,795.0

Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s nonvested shares as of December 31, 2017 and changes during the year ended December 31, 2017, including shares under both the 2009 Plan and the Inducement Plan, is as follows:
 
Shares
 
Weighted-
Average
Grant-Date
Fair Value
Nonvested at December 31, 2016
1,993,628

 
$
12.16

Granted
485,263

 
$
15.55

Vested
652,193

 
$
12.28

Forfeited
100,789

 
$
13.35

Nonvested at December 31, 2017
1,725,909

 
$
13.03